发表研究结果有使用 ab37305?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab37305 被引用在 4 文献中.

  • Zhao JJ  et al. miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/ß-catenin/BCL9 pathway. Cancer Res 74:1801-13 (2014). Human . PubMed: 24599134
  • Hyeon J  et al. Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma. Korean J Pathol 47:130-6 (2013). IHC-P ; Human . PubMed: 23667372
  • Takada K  et al. Targeted disruption of the BCL9/ß-catenin complex inhibits oncogenic Wnt signaling. Sci Transl Med 4:148ra117 (2012). IHC-P ; Human . PubMed: 22914623
  • Mani M  et al. BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells. Cancer Res 69:7577-86 (2009). WB ; Human . PubMed: 19738061

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"